secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2024-11-14T23:59:59+00:00
Accession:  0001493152-24-045361
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab Q3 revenue up 62% to $544K, net income $49.8K, gross margin 67.1%
------------------------------------------------------------------------

- Revenue $544,285 (+62% YoY); gross margin 67.1% (up from 56.3%). Net income $49,765 vs ($82,000) loss in Q3 2023.
- ISP (digital health) segment revenue up 126% in Q3 to ~$162K; YTD growth 143% to ~$450K.
- Allergy kit sales +48% YoY to ~$220K. Surpassed 100,000 completed digital assessments.
- Debt reduction of >$100K from operating cash flow; R&D investment up to $187K YTD.
- Secured ~$300K grant for allergic rhinitis digital health research.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000149315224045361/0001493152-24-045361-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000149315224045361/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-045361

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer